Vimarsana
Biggest News Aggregation in the World

Page 18 - Hf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hf Today - Breaking & Trending Today

Superior Health Foundation names new executive director - Vimarsana News

Superior Health Foundation names new executive director

MARQUETTE, Mich. (WJMN) — The Superior Health Foundation has chosen a new executive director as its long-time leader Jim LaJoie is set to retire later this year. Taking LaJoie’s place at the helm of the local health grant organization is U.P. native Megan Murphy. In a Tuesday release SHF said Murphy is a leader in […]

Source: yahoo.com
I worry my heart will fail while I'm still on a waiting list - Vimarsana News

I worry my heart will fail while I'm still on a waiting list

Over 1,000 people have been waiting for tests which could detect heart disease early for more than a year.

Source: yahoo.com
Similar Risk of Death Between Patients With HFimpEF, LVEF Above 40% in DELIVER Trial - Vimarsana News

Similar Risk of Death Between Patients With HFimpEF, LVEF Above 40% in DELIVER Trial

An analysis of the DELIVER trial also revealed an association between dapagliflozin treatment and reduced risk of cardiovascular death among individuals with heart failure with improved ejection fraction (HFimpEF).

Source: ajmc.com
Early deaths from heart disease soar to ten-year high in wake of Covid - Vimarsana News

Early deaths from heart disease soar to ten-year high in wake of Covid

Analysis by the British Heart Foundation (BHF) has found that 80 people in every 100,000 in England died from heart and circulatory diseases before the age of 75 in 2022.

Source: yahoo.com
STRONG-HF Analysis: More Rapid Uptitration of Heart Failure Therapies Confers Greater Benefit - Vimarsana News

STRONG-HF Analysis: More Rapid Uptitration of Heart Failure Therapies Confers Greater Benefit

Post hoc analysis of STRONG-HF trial underscores benefits of higher guideline-directed medical therapy doses in acute heart failure, showing lower rates of death or readmission at 6 months,